Understanding Chronic Lymphocytic Leukemia (CLL) with guest Dr. Joseph Ho
In this episode of Medical Insights with Dr. Thomas Blom, host Dr. Blom welcomes Dr. Joseph Ho, a Hematologist-Oncologist from the Princeton Medical Group. Together, they demystify Chronic Lymphocytic Leukemia (CLL), a diagnosis that often sounds urgent and frightening but frequently follows a very different path than other cancers.
From the initial shock of the word "leukemia" to modern, chemotherapy-free treatment options, this conversation provides a comprehensive overview for patients and families navigating a CLL diagnosis.
Key Topics Covered:
•Leukemia vs. Lymphoma: Understanding why CLL is considered a chronic, low-grade, and often non-aggressive disease rather than an immediate medical emergency.
•The "Watch and Wait" Paradigm: Why two-thirds to three-fourths of patients start with surveillance rather than active treatment. Dr. Ho explains why "stirring the pot" too early isn't always best for the patient.
•Triggers for Treatment: What doctors look for—such as drenching night sweats, fatigue, rapid white blood cell doubling time, or specific genetic markers like the p53 mutation—before starting therapy.
•Modern Treatment Options: How the field has moved away from traditional chemotherapy toward targeted oral therapies like Acalabrutinib and Venetoclax
•Living with CLL: Practical advice on vaccinations (including the importance of the Shingrix vaccine), infection risks, and maintaining a normal lifestyle without "living in a bubble".
•Long-term Risks & Family Planning: Discussing the slightly increased risk for skin cancers and the familial (but not directly inherited) nature of the disease.
About the Guest:
Dr. Joseph Ho is a Hematologist-Oncologist at the Princeton Medical Group in Princeton, New Jersey. He specializes in the treatment of blood cancers and provides expert insights into the evolving landscape of CLL management.
